Cargando…

Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series

Nowadays, Jin-Fu-Kang oral liquid (JFK), one of Chinese herbal medicines (CHMs) preparations, has been widely used as an adjuvant therapy for primary non-small cell lung cancer (PNSCLC) patients with the syndrome of deficiency of both Qi and Yin (Qi–Yin deficiency pattern) based on Traditional Chine...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Bin, Yang, Ming, Han, Zixin, Que, Zujun, Luo, Tianle, Tian, Jianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304868/
https://www.ncbi.nlm.nih.gov/pubmed/35875082
http://dx.doi.org/10.3389/fonc.2022.882278
_version_ 1784752188033073152
author Luo, Bin
Yang, Ming
Han, Zixin
Que, Zujun
Luo, Tianle
Tian, Jianhui
author_facet Luo, Bin
Yang, Ming
Han, Zixin
Que, Zujun
Luo, Tianle
Tian, Jianhui
author_sort Luo, Bin
collection PubMed
description Nowadays, Jin-Fu-Kang oral liquid (JFK), one of Chinese herbal medicines (CHMs) preparations, has been widely used as an adjuvant therapy for primary non-small cell lung cancer (PNSCLC) patients with the syndrome of deficiency of both Qi and Yin (Qi–Yin deficiency pattern) based on Traditional Chinese Medicine (TCM) theory. However, we found insufficient evidence of how long-term CHM treatment influence PNSCLC patients’ progression-free survival (PFS). Thus, using electronic medical records, we established a nomograph-based prognostic model for predicting PNSCLC patients’ PFS involved with JFK supplementary formulas (JFK-SFs) over 6 months, in order to preliminarily investigate potential predictors highly related to adjuvant CHMs therapies in theoretical epidemiology. In our retrospective study, a series of 197 PNSCLC cases from Long Hua Hospital were enrolled by non-probability sampling and divided into 2 datasets at the ratio of 5:4 by Kennard–Stone algorithm, as a result of 109 in training dataset and 88 in validation dataset. Besides, TNM stage, operation history, sIL-2R, and CA724 were considered as 4 highly correlated predictors for modeling based on LASSO-Cox regression. Additionally, we respectively used training dataset and validation dataset for establishment including internal validation and external validation, and the prediction performance of model was measured by concordance index (C-index), integrated discrimination improvement, and net reclassification indices (NRI). Moreover, we found that the model containing clinical characteristics and bio-features presented the best performance by pairwise comparison. Next, the result of sensitivity analysis proved its stability. Then, for preliminarily examination of its discriminative power, all eligible cases were divided into high-risk or low-risk progression by the cut-off value of 57, in the light of predicted nomogram scores. Ultimately, a completed TRIPOD checklist was used for self-assessment of normativity and integrity in modeling. In conclusion, our model might offer crude probability of uncertainly individualized PFS with long-term CHMs therapy in the real-world setting, which could discern the individuals implicated with worse prognosis from the better ones. Nevertheless, our findings were prone to unmeasured bias caused by confounding factors, owing to retrospective cases series.
format Online
Article
Text
id pubmed-9304868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93048682022-07-23 Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series Luo, Bin Yang, Ming Han, Zixin Que, Zujun Luo, Tianle Tian, Jianhui Front Oncol Oncology Nowadays, Jin-Fu-Kang oral liquid (JFK), one of Chinese herbal medicines (CHMs) preparations, has been widely used as an adjuvant therapy for primary non-small cell lung cancer (PNSCLC) patients with the syndrome of deficiency of both Qi and Yin (Qi–Yin deficiency pattern) based on Traditional Chinese Medicine (TCM) theory. However, we found insufficient evidence of how long-term CHM treatment influence PNSCLC patients’ progression-free survival (PFS). Thus, using electronic medical records, we established a nomograph-based prognostic model for predicting PNSCLC patients’ PFS involved with JFK supplementary formulas (JFK-SFs) over 6 months, in order to preliminarily investigate potential predictors highly related to adjuvant CHMs therapies in theoretical epidemiology. In our retrospective study, a series of 197 PNSCLC cases from Long Hua Hospital were enrolled by non-probability sampling and divided into 2 datasets at the ratio of 5:4 by Kennard–Stone algorithm, as a result of 109 in training dataset and 88 in validation dataset. Besides, TNM stage, operation history, sIL-2R, and CA724 were considered as 4 highly correlated predictors for modeling based on LASSO-Cox regression. Additionally, we respectively used training dataset and validation dataset for establishment including internal validation and external validation, and the prediction performance of model was measured by concordance index (C-index), integrated discrimination improvement, and net reclassification indices (NRI). Moreover, we found that the model containing clinical characteristics and bio-features presented the best performance by pairwise comparison. Next, the result of sensitivity analysis proved its stability. Then, for preliminarily examination of its discriminative power, all eligible cases were divided into high-risk or low-risk progression by the cut-off value of 57, in the light of predicted nomogram scores. Ultimately, a completed TRIPOD checklist was used for self-assessment of normativity and integrity in modeling. In conclusion, our model might offer crude probability of uncertainly individualized PFS with long-term CHMs therapy in the real-world setting, which could discern the individuals implicated with worse prognosis from the better ones. Nevertheless, our findings were prone to unmeasured bias caused by confounding factors, owing to retrospective cases series. Frontiers Media S.A. 2022-07-08 /pmc/articles/PMC9304868/ /pubmed/35875082 http://dx.doi.org/10.3389/fonc.2022.882278 Text en Copyright © 2022 Luo, Yang, Han, Que, Luo and Tian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Luo, Bin
Yang, Ming
Han, Zixin
Que, Zujun
Luo, Tianle
Tian, Jianhui
Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
title Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
title_full Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
title_fullStr Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
title_full_unstemmed Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
title_short Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
title_sort establishment of a nomogram-based prognostic model (lasso-cox regression) for predicting progression-free survival of primary non-small cell lung cancer patients treated with adjuvant chinese herbal medicines therapy: a retrospective study of case series
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304868/
https://www.ncbi.nlm.nih.gov/pubmed/35875082
http://dx.doi.org/10.3389/fonc.2022.882278
work_keys_str_mv AT luobin establishmentofanomogrambasedprognosticmodellassocoxregressionforpredictingprogressionfreesurvivalofprimarynonsmallcelllungcancerpatientstreatedwithadjuvantchineseherbalmedicinestherapyaretrospectivestudyofcaseseries
AT yangming establishmentofanomogrambasedprognosticmodellassocoxregressionforpredictingprogressionfreesurvivalofprimarynonsmallcelllungcancerpatientstreatedwithadjuvantchineseherbalmedicinestherapyaretrospectivestudyofcaseseries
AT hanzixin establishmentofanomogrambasedprognosticmodellassocoxregressionforpredictingprogressionfreesurvivalofprimarynonsmallcelllungcancerpatientstreatedwithadjuvantchineseherbalmedicinestherapyaretrospectivestudyofcaseseries
AT quezujun establishmentofanomogrambasedprognosticmodellassocoxregressionforpredictingprogressionfreesurvivalofprimarynonsmallcelllungcancerpatientstreatedwithadjuvantchineseherbalmedicinestherapyaretrospectivestudyofcaseseries
AT luotianle establishmentofanomogrambasedprognosticmodellassocoxregressionforpredictingprogressionfreesurvivalofprimarynonsmallcelllungcancerpatientstreatedwithadjuvantchineseherbalmedicinestherapyaretrospectivestudyofcaseseries
AT tianjianhui establishmentofanomogrambasedprognosticmodellassocoxregressionforpredictingprogressionfreesurvivalofprimarynonsmallcelllungcancerpatientstreatedwithadjuvantchineseherbalmedicinestherapyaretrospectivestudyofcaseseries